Abstract
Purpose
To assess and compare the studies conducted in the literature with recurrence rates and the summary of the justified treatment approaches be presented.
Method
Pterygium, a fibrovascular tissue that proceeds from the bulbar conjunctiva towards the cornea, is quite a commonly seen ocular surface deterioration. The treatment is performed through a surgical excision, and the frequent recurrence of this disorder, despite the developments of today, is the major problem experienced in the wake of the surgery. There are various treatment methods applied for the prevention of recurrence; yet, there is no definite view as to what treatment is the most effective one. Since the recurrent pterygium cases are more aggressive than the primary pterygium, it is of great importance to determine the treatment method in which recurrence rate is the lowest. In different studies seen in the literature, there is difficulty in comparing the results due to the fact that the follow-up periods, recurrence criteria and the doses and durations of the medications administered differ from one another.
Conclusion
When the literature is reviewed, the bare sclera technique is not used due to the high rate of recurrence, whereas successful results can be achieved through the conjunctival autograft technique. Lower recurrence rates have been reported along with the administration of mitomycin C, 5-FU and other agents that were used as an adjuvant treatment.
Similar content being viewed by others
References
Hill JC, Maske R (1989) Pathogenesis of pterygium. Eye 3:218–226 (Lond)
Mohammed I (2011) Treatment of pterygium. Ann Afr Med 10(3):197–203
Cameron ME (1965) Pterygium throughout the world. Charles C. Thomas, Springfield
Coroneo MT, Giirolamo ND, Wakefield D (1999) The pathogenesis of pterygia. Curr Opin Ophtalmol 10:282–288
Mackenzie FD, Hirst LW, Battistutta D, Green A (1992) Risk analysis in the development of pterygia. Ophthalmology 99:1056–1061
Butrus SI, Ashaf MF, Laby DM, Rabinovvitz AL et al (1995) Increased numbers of mast cellsin pterygia. Am J Ophthalmol 119:236–237
Di Girolamo N, Chui J, Coroneo MT, Wakefield D (2004) Pathogenesis of pterygia: role of cytokines, growth factors, and matrix metalloproteinases. Prog Retin Eye Res 23:195–228
Tekelioglu Y, Turk A, Avunduk AM et al (2006) Flow cytometrical analysis of adhesion molecules, T-lymphocyte subpopulations and inflammatory markers in pterygium. Ophthalmologica 220:372–378
Hilgers JH (1960) Pterygium: its incidence, heredity and etiology. Am J Ophthalmol 50:635–644
Onur C, Orhan D, Orhan M, Sak SD, Tulunay O, Irkec M (1998) Expression of p53 protein in pterygium. Eur J Ophthalmol 8:157–161
Reisman D, McFadden JW, Lu G (2004) Loss of heterozygosity and p53 expression in pterygium. Cancer Lett 206:77–83
Detorakis ET, Spandidos DA (2009) Pathogenetic mechanisms and treatment options for ophtalmic pterjıum: trends and perspectives. Int J Mol Med 23:439–447
Hoffman RS, Power WJ (1999) Current options in pterygium management. Int Ophthalmol Clin 39:15–26
Hirst LW (2003) The treatment of pterygium. Surv Ophthalmol 48:145–180
Alpay A, Uğurbaş Ş, Erdoğan B (2009) Comparing techniques for pterygıum. Clin Ophthalmol 3:69–74
Ozer A, Yildirim N, Erol N, Yurdakul S (2009) Long-term results of bare sclera, limbal-conjunctival autograft and amniotic membrane graft techniques in primary pterygium excisions. Ophthalmologica 223:269–273
Kareem AA, Farhoood Q, Alhammami H (2012) The use of antimetabolites as adjunctive therapy in the surgical treatment of pterygium. Clin Ophthalmol 6:1849–1854
Yanyali AC, Talu H, Alp BN, Karabas L, Ay GM, Caglar Y (2000) Intraoperative mitomycin C in the treatment of pterygium. Cornea 19(4):471–473
Demirok A, Simsek S, Cinal A, Yasar T (1998) Intraoperative application of mitomycin C in the surgical treatment of pterygium. Eur J Ophthalmol 8(3):153–156
Verma N, Garap JA, Maris R, Kerek A (1998) Intraoperative use of mitomycin C in the treatment of recurrent pterygium. P N G Med J 41(1):37–42
Mastropasqua L, Carpineto P, Ciancaglini M, Enrico Gallenga P (1996) Long term results of intraoperative mitomycin C in the treatment of recurrent pterygium. Br J Ophthalmol 80(4):288–291
Kenyon KR, Wagoner MD, Hettinger ME (1985) Conjunctival autografttransplantation for advanced and recurrent pterygium. Ophthalmology 92:1461–1470
Lewallen S (1989) A randomized trial of conjunctival autografting for pterygium in the tropics. Ophthalmology 96:1612–1614
Allan BD, Short P, Crakford GJ, Barret GD, Constable IJ (1993) Pterygium excision with conjunctival autografting: an effective and safe technique. Br J Ophthalmol 77(11):698–703
Ti SE, Chee SP, Dear KB et al (2000) Analysis of variation in success rates in conjunctival autografting for primary and recurrent pterygium. Br J Ophthalmol 84:385–389
Kmiha N, Kamoun B, Trigui A, Jelliti B, Fourati M, Chaabouni M (2001) Effectiveness of conjunctival autograft transplantation in pterygium surgery. J Fr Ophtalmol 24(7):729–732
Seid A, Bejiga A (2000) Free conjunctival autograft in the management of advanced primary and recurrent pterygia. East Afr Med J 77(11):588–591
Chaidaroon W, Wattananikorn S (2003) Conjunctival autograft transplantation for primary pterygium. J Med Assoc Thai 86(2):111–115
Huerva V, March A, Martinez-Alonso M, Muniesa MJ, Sanchez C (2012) Pterygium surgery by means of conjunctival autograft: long term follow-up. Arq Bras Oftalmol 75(4):251–255
Varssano D, Shalev H, Lazar M, Fischer N (2013) Pterygium excision with conjunctival autograft: true survival rate statistics. Cornea 32(9):1243–1250
Kocamis O, Bilgec M (2014) Evaluation of the recurrence rate for pterygium treated with conjunctival autograft. Graefes Arch Clin Exp Ophthalmol 252(5):817–820
Koranyi G, Seregard S, Kopp ED (2005) The cut-and-paste method for primary pterygium surgery: long-term follow-up. Acta Ophthalmol Scand 83:298–301
Marticorena J, Rodriguez-Ares MT, Tourino R et al (2006) Pterygium surgery: conjunctival autograft using a fibrin adhesive. Cornea 25:34–36
Bahar I, Weinberger D, Dan G, Avisar R (2006) Pterygium surgery: fibrin glue versus vicryl sutures for conjunctival closure. Cornea 25:1168–1172
Uy HS, Reyes JM, Flores JD, Lim-Bon-Siong R (2005) Comparison of fibrin glue and sutures for attaching conjunctival autografts after pterygium excision. Ophthalmology 112:667–671
Bahar I, Weinberger D, Gaton DD et al (2007) Fibrin glue versus vicryl sutures for primary conjunctival closure in pterygium surgery: long-term results. Curr Eye Res 32:399–405
Karalezli A, Kucukerdonmez C, Akova YA, Altan-Yaycioglu R, Borazan M (2008) Fibrin glue versus suturesfor conjunctival autografting in pterygium surgery: a prospective comparative study. Br J Ophthalmol 92(9):1206–1210
Ratnalingam V, Eu AL, Ng GL, Taharin R, John E (2010) Fibrin adhesive is better than sutures in pterygium surgery. Cornea 29(5):485–489
Nieuwendaal CP, van der Meulen IJ, Mourits M, Lapid-Gortzak R (2011) Long-term follow-up of pterygium surgery using a conjunctival autograft and tissucol. Cornea 30(1):34–36
Kurian A, Reghunadhan I, Nair KG (2015) Autologous blood versus fibrin glue for conjunctival autograft adherence in sutureless pterygium surgery: a randomised controlled trial. Br J Ophthalmol 99(4):464–470
Boucher S, Conlon R, Teja S, Teichman JC, Yeung S, Ziai S, Baig K (2015) Fibrin glue versus autologous blood for conjunctival autograft fixation in pterygium surgery. Can J Ophthalmol 50(4):269–272
Choudhury S, Dutta J, Mukhopadhyay S, Basu R, Bera S, Savale S, Sen D, Datta H (2014) Comparison of autologous in situ blood coagulum versus sutures for conjunctival autografting after pterygiumexcision. Int Ophthalmol 34(1):41–48
Singh PK, Singh S, Vyas C, Singh M (2013) Conjunctival autografting without fibrin glue or sutures for pterygium surgery. Cornea 32(1):104–107
Gris O, Guell JL, del Campo Z (2000) Limbal-conjunctival autograft transplantation for the treatment of recurrent pterygium. Ophthalmology 107:270–273
Oguz H (2003) Inferior limbal conjunctival autograft transplantation for recurrent pterygium. Indian J Ophthalmol 51:108–109
Al-Fayez MF (2002) Limbal versus conjunctival autograft transplantation for advanced and recurrent pterygium. Ophthalmology 109:1752–1755
Malik KP, Goel R, Gutpa A, Gupta SK, Kamal S, Mallik VK, Singh S (2012) Efficacy of sutureless and glue free limbal conjunctival autograft for primary pterygium surgery. Nepal J Ophthalmol 4(2):230–235
Al Fayez MF (2013) Limbal-conjunctival versus conjunctival autograft transplant for recurrent pterygia: a prospective randomized controlled trial. JAMA Ophthalmol 131(1):11–16
Masters JS, Harris DJ Jr (2015) Low recurrence rate of pterygium after excision with conjunctival limbal autograft: a retrospective study with long-term follow-up. Cornea 34(12):1569–1572. doi:10.1097/ICO.0000000000000597
Shimazaki J, Shinozaki N, Tsubota K (1998) Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon. Br J Ophthalmol 82:235–240
Shimazaki J, Kosaka K, Shimmura S, Tsubota K (2003) Amniotic membrane transplantation with conjunctival autograft for recurrent pterygium. Ophthalmology 110:119–124
Kucukerdönmez C, Akova YA, Altinors DD (2007) Comparison of conjunctival autograft with amniotic membrane transplantation for pterygium surgery: surgical and cosmetic outcome. Cornea 26:407–413
Okoye O, Oguego NC, Chuka Okosa CM, Ghanta M (2013) Short term results of pterygium surgery with adjunctive amniotic membrane graft. Niger J Clin Pract 16(3):356–359. doi:10.4103/1119-3077.113463
Arain MA, Yaqub MA, Ameen SS, Iqbal Z, Naqvi AH, Niazi MK (2012) Amniotic membrane transplantation in primary pterygium compared with bare sclera technique. J Coll Physicians Surg Pak 22(7):440–443
Solomon A, Pires RT, Tseng SC (2001) Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108:449–460
Essex RW, Snibson GR, Daniell M, Tole DM (2004) Amniotic membrane grafting in the surgical management of primary pterygium. Clin Exp Ophthalmol 32(5):501–504
Liang W, Li R, Deng X (2012) Comparison of the efficacy of pterygium resection combined with conjunctival autograft versus pterygium resection combined with amniotic membrane transplantation. Eye Sci 27(2):102–105
Tananuvat N, Martin T (2004) The results of amniotic membrane transplantation for primary pterygium compared with conjunctival autograft. Cornea 23:458–463
Luanratanakorn P, Ratanapakorn T, Suwan-apichon O et al (2006) Randomised controlled study of conjunctival autograft versus amniotic membrane graft in pterygium excision. Br J Ophthalmol 90:1476–1480
Kaufman S, Jacobs D, Lee W et al (2013) Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology. Ophthalmology 120:201–208
Paracha Q, Ayoob M, Dawood Z, Mirza SA (2014) Recurrence rate with use of intraoperative mitomycin C versus conjunctival autograft following pterygium excision. Pak J Med Sci 30(6):1243–1246. doi:10.12669/pjms.306.5191
Young AL, Ho M, Jhanji V, Cheng LL (2013) Ten-year results of a randomized controlled trial comparing 0.02 % mitomycin C and limbal conjunctival autograft in pterygium surgery. Ophthalmology 120(12):2390–2395
Malek I, Zghal I, Chebbi A, Lajili Z, Boujemaa C, Nacef L, Bouguila H, Saida Ayed S (2013) Conjunctival limbal autograft versus simple excision with intra-operative mitomycin C in pterygium surgery: a comparative study. J Fr Ophtalmol 36(3):230–235
Frucht-Pery J, Raiskup F, Ilsar M, Landau D, Orucov F, Solomon A (2006) Conjunctival autografting combined with low-dose mitomycin C for prevention of primary pterygium recurrence. Am J Ophthalmol 141(6):1044–1050
Masuda A, Takahashi K, Nejima R, Minami K, Miyata K (2013) Pterygium excision using bulbar conjunctival autograft with intraoperative mitomycin C for primary pterygium: a retrospective assessment of 1832 eyes. Nippon Ganka Gakkai Zasshi 117(9):743–748
Altiparmak UE, Katircioğlu YA, Yağci R, Yalniz Z, Duman S (2007) Mitomycin C and conjunctival autograft for recurrent pterygium. Int Ophthalmol 27(6):339–343
Shehadeh-Mashor R, Srinivasan S, Boimer C, Lee K, Tomkins O, Slomovic AR (2011) Management of recurrent pterygium with intraoperative mitomycin C and conjunctival autograft with fibrin glue. Am J Ophthalmol 152(5):730–732
Rubinfeld RS, Pfister RR, Stein RM, Foster CS, Martin NF, Stoleru S, Talley AR, Speaker MG (1992) Serious complications of topical mitomycin-C after pterygium surgery. Ophthalmology 99(11):1647–1654
Dougherty PJ, Hardten DR, Lindstrom RL (1996) Corneoscleral melt after pterygium surgery using a single intraoperative application of mitomycin-C. Cornea 15(5):537–540
Hayasaka S, Ieasa Y, Nagaki Y, Kadoi C, Matsumoto M, Hayasaka Y (2000) Late complications after pterygium excision with high dose mitomycin C instillation. Br J Ophthalmol 84(9):1081–1082
Safianik B, Ben-Zion I, Garzozi HJ (2002) Serious corneoscleral complications after pterygium excision with mitomycin C. Br J Ophthalmol 86(3):357–358
Shi WY, Wang FH (2013) Mitomycin C related complications shouldn’t be neglected in the pterygium surgery. J Ophthalmol 49(10):869–872
Ngoy D, Kayembe L (1998) A comparative study of thiotepa and mitomycin C in the treatment of pterygium. Preliminary results. J Fr Ophtalmol 21(2):96–102
Tassy A, Ribe D (1999) Thiotepa eyedrops for prevention of pterygium recurrence: 18 years of use. J Fr Ophtalmol 22(2):215–219
Wu H, Chen G (1999) Cyclosporine A and thiotepa in prevention of postoperative recurrence of pterygium. Yan Ke Xue Bao 15(2):91–92
Akarsu C, Taner P, Ergin A (2003) 5-Fluorouracil as chemoadjuvant for primary pterygium surgery: preliminary report. Cornea 22(6):522–526
Bekibele CO, Baiyeroju AM, Olusanya BA, Ashaye AO, Oluleye TS (2008) Pterygium treatment using 5-FU as adjuvant treatment compared to conjunctiva autograft. Eye 22(1):31–34 (Lond)
Bekibele CO, Ashaye A, Olusanya B, Baiyeroju A, Fasina O, Ibrahim AO, Ogun O (2012) 5-Fluorouracil versus mitomycin C as adjuncts to conjunctival autograft in preventing pterygium recurrence. Int Ophthalmol 32(1):3–8. doi:10.1007/s10792-011-9509-x
Salustiano Correa E, Silva R, de Pereira Avila M, Rassi AR, Ximenes L, da Silva DS Jr, de Paula AC (2013) Intraoperative use of 5-fluorouracil in pterygium surgery: a comparative study. Semin Ophthalmol 28(1):34–36
Teng CC, Patel NN, Jacobson L (2009) Effect of subconjunctival bevacizumab on primary pterygium. Cornea 28(4):468–470
Leippi S, Grehn F, Geerling G (2009) Antiangiogenic therapy for pterygium recurrence. Ophthalmologe 106(5):413–419
Kocabora SM, Fazıl K, Ozsutcu M, Doyduk Kocabora A, Gulkılık G (2013) Subconjunctival bevacizumab injection in the surgery or primary pterygium: comparison with intraoperative mitoymcin-C. Bull Soc Belge Ophtalmol 322:7–12
Shenasi A, Mousavi F, Shoa-Ahari S, Rahimi-Ardabili B, Fouladi RF (2011) Subconjunctival bevacizumab immediately after excision of primary pterygium: the first clinical trial. Cornea 30(11):1219–1222
Shahin MM, Elbendary AM, Elwan MM (2012) Intraoperative subconjunctival bevacizumab as an adjunctive treatment in primary pterygium: a preliminary report. Ophthalmic Surg Lasers Imaging 43(6):459–466. doi:10.3928/15428877-20120802-02
Razeghinejad MR, Banifatemi M (2014) Subconjunctival bevacizumab for primary pterygium excision; a randomized clinical trial. J Ophthalmic Vis Res 9(1):22–30
Kasetsuwan N, Reinprayoon U, Satitpitakul V (2015) Prevention of recurrent pterygium with topical bevacizumab 0.05 % eye drops: a randomized controlled trial. Clin Ther 37(10):2347–2351
Wu P, Kuo H, Tai M, Shin S (2009) Topical bevacizumab eyedrops for limbal-conjunctival neovascularization in impending recurrent pterygium. Cornea 28:103–104
Ozgurhan EB, Agca A, Kara N et al (2013) Topical application of bevacizumab as an adjunct to recurrent pterygium surgery. Cornea 32:835–838
Fallah MR, Khosravi K, Hashemian MN et al (2010) Efficacy of topical bevacizumab for inhibiting growth of impending recurrent pterygium. Curr Eye Res 35:17–22
Yamada T, Mochizuki H, Ue T, Kiuchi Y, Takahashi Y, Oinaka M (2011) Comparative study of different β-radiation doses for preventing pterygium recurrence. Int J Radiat Oncol Biol Phys 81(5):1394–1398
Ali AM, Thariat J, Bensadoun RJ, Thyss A, Rostom Y, El-Haddad S, Gérard JP (2011) The role of radiotherapy in the treatment of pterygium: a review of the literature including more than 6000 treated lesions. Cancer Radiother 15(2):140–147
Mourits MP, Wyrdeman HK, Jurgenliemk-Schulz IM, Bidlot E (2008) Favorable long-term results of primary pterygium removal by bare sclera extirpation followed by a single 90 strontium application. Eur J Ophthalmol 18(3):327–331
Pajic B, Greiner RH (2005) Long term results of non-surgical, exclusive strontium-/yttrium-90 beta-irradiation of pterygia. Radiother Oncol 74(1):25–29
MacKenzie FD, Hirst LW, Kynaston B, Bain C (1991) Recurrence rate and complications after beta irradiation for pterygia. Ophthalmology 98(12):1776–1780
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Hacıoğlu, D., Erdöl, H. Developments and current approaches in the treatment of pterygium. Int Ophthalmol 37, 1073–1081 (2017). https://doi.org/10.1007/s10792-016-0358-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-016-0358-5